Screening and monitoring cholesterol levels is an effective way to reduce the risks associated with heart disease. During Project ImPACT Hyperlipidemia study, 93% (vs. 25%) of patients tested with the Cholestech LDX system achieved compliance to therapy rates and attained NCEP goals of 62% (vs.

8%) in earlier studies. The procedure is simple. A drop of blood is taken from the finger and placed in a cassette. After a few minutes, the instrument generates a report providing you with total cholesterol, HDL, LDL, triglycerides and more. A new liver function ALT (GPT) test to monitor the

potential side effects of cholesterol-lowering drug therapies is now available.